IGF2BP3 and nasopharyngeal carcinoma: Previous evidence suggested that IGF2BP3 was upregulated in NPC tissues and promoted EMT by activating AKT/mTOR signaling [48], which could be activated in the noncanonical Notch signaling pathway [14, 49].